monotherapy

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  

monotherapy
Sep 24, 2024, 16:24 | Insight
Combination vs monotherapy for management of myelofibrosis
Talha Badar posted on X: "Interesting debate on combination vs monotherapy for management of myelofibrosis. Efficacy…
Jul 19, 2024, 22:56 | Insight
Stunning interim clinical trial data from Revolution Medicines
Grainne O'Kane, Medical Oncologist at Princess Margaret Cancer Centre, shared a post by Kenneth Olive,…
Jul 10, 2024, 06:36 | Insight
Paolo Tarantino: Intersecting data with the MAT2A inhibitor IDE397 in MTAPdel lung and urothelial cancer
Paolo Tarantino shared a post by Bio Stocks on X, adding: . "Intersecting data with…
May 6, 2024, 19:10 | Blog
Erman Akkus: ASCO Ed book on mNSCLC without oncogenic alterations
Erman Akkus, medical oncologist at Ankara Medical University, shared on Twitter/X: "Metastatic NSCLC without oncogenic…
May 2, 2024, 15:25 | Blog
Tanja Obradovic: Interesting updates will be coming on ASCO 2024
Tanja Obradovic, Vice President of  Oncology Scientific Affairs at ICON, shared on LinkedIn: "ASCO 2024 is almost…
Aug 11, 2023, 17:44 | Insight
Vivek Subbiah: Pleased to share our back-to-back papers unveiling promising results of Lurbinectedin
Hot off the press Pleased to share our back-to-back papers unveiling promising results of Lurbinectedin.…
Jul 11, 2023, 15:33 | Drugs
First patient dosed in combination trial of OBT076 and CPI Balstilimab - Oxford BioTherapeutics
We are pleased to announce that the first patient has been dosed in a Phase…
Jul 10, 2023, 03:08 | Opinion
Study showed better OS & quality of life with Atezo - Rami Manochakian, MD
Hot off the press @TheLancet IPSOS phase 3 trial of 1st line Atezolizumab monotherapy vs…
Jun 19, 2023, 18:11 | Drugs
Antibody-drug conjugates (ADCs) have emerged as one of the fastest-growing oncology therapeutics - Antonio Passaro
I am delighted to share the our recent publication in JCO titled "Antibody-Drug Conjugates in…
All: 9 Posts: 1 - 100
Special Coverage